QUEBEC CITY, May 1st, 2014 /CNW/ - Opsens Inc. ("Opsens" or "the Company") (TSXV: OPS), a company focusing on two high-growth markets, measurement of Fractional Flow Reserve ("FFR") in medical instrumentation and oil and gas, has won two awards at the 7th Annual Stock Company Gala, held in Quebec on April 29, 2014.
Opsens wins Gold and IBR-QCA Awards
Opsens received one of the most prestigious awards of the evening, winning the Gold Award, which recognizes the company with the best stock market performance among firms listed on the TSX Venture Exchange. Opsens also won the Regional Performance Award, which is bestowed upon the company that performed best in the Quebec area. In his acceptance speech, Louis Laflamme, President and CEO of Opsens, said: "This award belongs to the employees and partners of the Company, who are committed to making Opsens a jewel of the Quebec economy."
A positive and active start for 2014
In addition to the awards received yesterday, Opsens is proud of its recent accomplishments, which include:
- The submission of Opsens' FFR products for approval in Japan;
- An $8.5 million equity financing with RBC Capital Markets, including Paradigm Capital Inc. and,
- The grant of a US$6 million license to Abiomed, Inc. for Opsens' miniature optical pressure sensor technology for applications in heart pump circulatory assist devices.
With these steps completed, Opsens is now poised to tackle other milestones for its FFR products, such as preparing to test its FFR products in humans, the final regulatory filings in the U.S. and Europe and, for oil and gas, expanding its base of recurring customers.
About Opsens Inc. (www.opsens.com)
Focusing on two main growth markets, FFR in medical instrumentation and oil and gas, Opsens develops, manufactures and installs systems to measure pressure and temperature as well as other parameters using fiber optic sensing technologies. These systems are designed around patented technologies that are effective and durable in extreme conditions.
Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: OPSENS INC.
For further information: Thierry Dumas, CPA, CA, Chief Financial Officer, 418.682.9996; Louis Laflamme, CPA, CA, Chief Executive Officer, 418.682.9996